摘要
Background: A high level of lipoprotein(a) can lead to a high risk of cardiovascular events or mortality. However, the association of moderately elevated lipoprotein(a) levels (>= 15 mg/dL) with long-term prognosis among patients with coronary artery disease (CAD) is still uncertain. Hence, we aim to systematically analyzed the relevance of baseline plasma lipoprotein(a) levels to long-term mortality in a large cohort of CAD patients. @@@ Methods: We obtained data from 43,647 patients who were diagnosed with CAD and had follow-up information from January 2007 to December 2018. The patients were divided into two groups (< 15 and >= 15 mg/dL). The primary endpoint was long-term all-cause death. Kaplan-Meier curve analysis and Cox proportional hazards models were used to investigate the association between moderately elevated baseline lipoprotein(a) levels (>= 15 mg/dL) and long-term all-cause mortality. @@@ Results: During a median follow-up of 5.04 years, 3,941 (18.1%) patients died. We observed a linear association between lipoprotein(a) levels and long-term all-cause mortality. Compared with lipoprotein(a) concentrations < 15 mg/dL, lipoprotein(a) >= 15 mg/dL was associated with a significantly higher risk of all-cause mortality [adjusted hazard ratio (aHR) 1.10, 95%CI: 1.04-1.16, P-values = 0.001). Similar results were found for the subgroup analysis of non-acute myocardial infarction, non-percutaneous coronary intervention, chronic heart failure, diabetes mellitus, or non-chronic kidney diseases. @@@ Conclusion: Moderately elevated baseline plasma lipoprotein(a) levels (>= 15 mg/dL) are significantly associated with higher all-cause mortality in patients with CAD. Our finding provides a rationale for testing the lipoprotein(a)-reducing hypothesis with lower targets (even < 15 mg/dL) in CAD outcome trials.
学科与关键词
- Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease PatientsYao, Younan; Liu, Jin; Wang, Bo; Zhou, Ziyou; Lu, Xiaozhao; Huang, Zhidong; Deng, Jingru; Yang, Yongquan; Tan, Ning; Chen, Shiqun*; Chen, Jiyan*; Liu, Yong*Frontiers in Cardiovascular Medicine, 2022, 8: 817442.被引 1
- Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort StudyHuang, Zhidong; Yang, Yanfang; Lu, Jin; Liang, Jingjing; He, Yibo; Yu, Yaren; Huang, Haozhang; Li, Qiang; Wang, Bo; Li, Shanggang; Yan, Zelin; Xu, Danyuan; Liu, Yong; Chen, Kaihong; Huang, Zhigang; Ni, Jindong; Liu, Jin*; Chen, Liling*; Chen, Shiqun*Frontiers in Cardiovascular Medicine, 2021, 8: 747120.被引 3
- Association of high-sensitivity C-reactive protein and long-term mortality may differ from lipoprotein(a) levels among patients undergoing coronary angiographyGuo, Z.; Lei, L.; Ying, M.; Wang, B.; Liu, J.; Liu, L.; He, Y.; Sun, G.; Chen, S.; Liu, B.; Chen, G.; Chen, J.; Liu, Y.European-Society-of-Cardiology (ESC) Congress, ELECTR NETWORK, 2020-08-29 To 2020.
